Anthem (Elevance Health) Ventures

Anthem (Elevance Health) Ventures is the corporate venture arm of Elevance Health, the Indianapolis-based payor that operates Blue Cross and Blue Shield plans across fourteen states and serves tens of millions of members nationally. As one of the largest payor venture programs in the country, the fund has a unique vantage point on cost, utilization, member experience, and provider operations, and deploys capital in service of those priorities.

The thesis is centered on care delivery, tech-enabled services, and digital health platforms that move the needle on cost of care or quality. That includes value-based care enablement, AI applications in claims and operations, tech-enabled care for chronic conditions, behavioral health platforms, home-based and virtual care, member engagement and navigation, and software that improves provider operations in ways that benefit risk-bearing entities. Companies whose business model aligns with Elevance Health’s interests as a payor and integrated services operator are firmly in scope.

Investments span Series A through growth, with checks generally in the five to twenty-five million dollar range. Geographic focus is the United States, with a natural pull toward markets where Elevance Health has significant member presence. The fund is comfortable leading or co-leading at growth stage and is selective at earlier stages, where it typically participates alongside healthcare-specialist financial investors.

As a corporate venture group, Anthem Ventures works closely with Elevance Health business leaders across health plan, Carelon services, and pharmacy. Decisions involve corporate development and senior business sponsors, which means diligence tends to involve operators who actually run the relevant programs. Founders should expect detailed conversations about contracting, data-sharing, and how a pilot would translate into measurable medical cost or quality outcomes.

The value proposition for founders is concrete. Portfolio companies can pursue contracting conversations with Elevance Health and its Carelon services businesses, access membership data and analytics for evidence generation, and benefit from a payor partner that takes value-based care arrangements seriously. The trade-off is meaningful: an explicit alignment with one major payor can complicate later contracting with United, CVS Aetna, and the other Blue plans, and information rights deserve careful evaluation. The fit is strongest for companies whose entire business model depends on payor relationships, where the access advantage clearly outweighs the alignment cost, and weaker for horizontal software companies that simply have payor customers among many. Founders considering this capital should be honest about whether they are building for the payor channel or simply selling into it, and structure terms accordingly.